The article discusses the personal journey of a daughter whose mother was diagnosed with squamous cell carcinoma. Faced with a grim prognosis, they explored treatment options and decided on Libtayo, an innovative immunotherapy. Despite concerns regarding its interaction with her mother’s polymyalgia rheumatica, they moved forward with the treatment. Remarkably, within four months, scans indicated a 95% reduction in cancer, showcasing the potential effectiveness of immunotherapy in fighting cancer and improving patient outcomes, even in challenging situations.
Libtayo is an immunotherapy that empowers the body's immune system to fight cancer more effectively, presenting a hopeful alternative to traditional treatments.
We chose Libtayo despite uncertainties due to my mom's polymyalgia rheumatica, and the results were astounding—her cancer shrank by 95% in four months.
Collection
[
|
...
]